Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyProtocol groupTransplantationDiseaseHodgkin LymphomaMantle Cell LymphomaNHL, B-Cell Type, Diffuse Large CellNHL, B-Cell Type, Follicular Grade I-IIIaNHL, B-Cell Type, Follicular grade IIIbStem Cell Transplantation, AutologousSubgroupICD10C81.-C82.-C82.7C82.9C83.1C83.3Z94.80MeSHHodgkin DiseaseTransplantation, AutologousSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBendamustineCarmustineCiprofloxacinCotrimoxazoleCytarabineDexamethasoneEtoposideFosaprepitantGranisetronMelphalanThiotepaValaciclovirSupportive substanceBalanced Crystalloid SolutionBendamustineCarmustineCiprofloxacinCotrimoxazoleCytarabineDexamethasoneEtoposideFosaprepitantGranisetronMelphalanThiotepaValaciclovirSupportive substanceBalanced Crystalloid SolutionBendamustineCarmustineCiprofloxacinCotrimoxazoleCytarabineDexamethasoneEtoposideFosaprepitantGranisetronMelphalanThiotepaValaciclovirSupportive substanceBalanced Crystalloid SolutionBendamustineCarmustineCiprofloxacinCotrimoxazoleCytarabineDexamethasoneEtoposideFosaprepitantGranisetronMelphalanThiotepaValaciclovirNo. Substances11Protocol classificationTherapy classificationalternativecurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationRelapse therapyseveral possibleTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksDiarrheaEmetogenicity (MASCC/ESMO)Gastrointestinal ToxicityHepatotoxicityInfectionsMucositisOral MucositisPyrexia only studiesPublicationAuthorCaballero MDKeil FLadetto MDiseaseNHL, HL, Rezidiv, fehlende Remission nach kurativer ChemotherapieNHL oder HL, auto-SZTRefraktäres oder rezidivierendes NHL oder HLOrigin3rd Medical Department for Haematology and Oncology, Hanusch Hospital, Vienna, AustriaDepartment of Hematology, Hospital Universitario Salamanca, SpanienDepartment of Translational Medicine, University of Eastern Piedmont, Novara, ItalyProtokolle in Überarbeitung 3 protocols foundBEAM - Carmustine 300 / Etoposide 200 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation (PID280 V2.2)Revision: BeEAM - Bendamustine 200 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation (PID879 V1.1)Revision: TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation (PID406 V2.1)
